ClinicalTrials.gg
CompletedNCT07943819Updated Nov 17, 2026

Salivary Stress Biomarkers in the Pediatric Surgical Patient

An interventional study of Parental presence during induction of anaesthesia and Midazolam in Anxiety, Stress Response and Pediatric Surgery, sponsored by Hospital Mutua de Terrassa. Completed at 1 site in Spain. Open to participants aged 4 Years to 9 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Hospital Mutua de Terrassa · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Nov 2023, registered Nov 2026).
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
176
Allocation
Randomized
Ages
4 Years to 9 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if salivary stress biomarkers can detect differences in stress level in children undergoing elective surgical procedures depending on the presence or not of their parents during anesthetic induction.

The questions we would like to answer are:

  • Does the presence of parents reduce stress in children undergoing surgery?
  • Does the level of salivary stress biomarkers correlate with the traditional subjective stress scores?
  • Does the stress in parents change if the accompany their children in the operating room? Researches will compare the levels of biomarkers and the stress score in both groups. They will also analyze the stress level of parents in each group.

Participants will:

  • Be randomize either to enter the operating room with their parents or not
  • Provide two saliva samples
  • Their parents will fill in the stress score questionnaires.
02

Conditions studied

  • Anxiety
  • Stress Response
  • Pediatric Surgery

Browse trials for

Keywords

  • anxiety
  • stress response
  • pediatric surgery
  • anesthetic induction
  • parenteral presence
03

In context

Anxiety Disorders Unverified

7,231 studies on the registry are indexed under Anxiety Disorders; 1,686 are open to participants now.

This study's enrollment of 176 is above the median of 80 across 6,085 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Hospital Mutua de Terrassa is the lead sponsor of 36 studies on the registry; 12 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
4 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Children aged 4 to 9 years undergoing elective surgery under general anaesthesia, either as day-case or inpatient procedures.

Exclusion criteria

Exclusion Criteria:

  • Previous surgical procedures under general anaesthesia.
  • Known psychological or psychiatric disorders.
  • Medical conditions that could interfere with salivary biomarker assessment.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
176 participants (actual)

Study arms

  • Active comparator
    Oral midazolam premedication

    Participants received oral midazolam at a dose of 0.3 mg/kg, administered 20 minutes before transfer to the operating room, as routine protocol. Parents were not present during anaesthetic induction.

    Drug: Midazolam

  • Experimental
    Parental presence

    One parent or caregiver was present during anaesthetic induction. No pharmacological premedication with midazolam was administered.

    Other: Parental presence during induction of anaesthesia

Interventions

  • OtherParental presence during induction of anaesthesia

    Presence of one parent or caregiver during the child's induction of general anaesthesia.

  • Oral midazolam administered at a dose of 0.3 mg/kg, 20 minutes before transfer to the operating room.

06

What researchers measure

Primary outcomes

  1. Modified Yale Preoperative Anxiety Scale (m-YPAS)

    Behavioural anxiety was assessed during anaesthetic induction using the modified Yale Preoperative Anxiety Scale (m-YPAS), a validated observational scale for measuring anxiety in children in the perioperative setting. Higher scores indicate greater anxiety.

    Time frame: During anaesthetic induction

Secondary outcomes

  1. Salivary cortisol levels

    Salivary cortisol concentrations measured at baseline and during anaesthetic induction to assess the biological stress response.

    Time frame: At baseline (before the intervention) and during anaesthetic induction.

  2. Salivary alpha-amylase levels

    Salivary alpha-amylase concentrations measured at baseline and during anaesthetic induction as a marker of autonomic nervous system activity.

    Time frame: At baseline (before the intervention) and during anaesthetic induction.

  3. Post-Hospitalization Behavior Questionnaire (PHBQ-27) score

    Postoperative behavioural changes assessed using the Post-Hospitalization Behavior Questionnaire (PHBQ-27), completed by parents or caregivers.

    Time frame: 15 days after surgery.

07

Study locations

1 site
  • Hospital Universitario Mutua de Terrassa
    Terrassa, Barcelona 08221, Spain
08

References and documents

Publications

  • Velayos M, Estefania K, Alvarez M, Sarmiento MC, Moratilla L, Sanabria P, Hernandez F, Lopez Santamaria MV. Healthcare staff as promoters of parental presence at anesthetic induction: Net Promoter Score survey. World J Clin Pediatr. 2021 Nov 9;10(6):159-167. doi: 10.5409/wjcp.v10.i6.159. eCollection 2021 Nov 9. PubMed 34868892 ↗
  • Anieta Merin Jacob , A.P., Maria Priscilla David. Stress Biomarkers in Saliva - An Overview. Ijcmr . Volume 8 Issue 2 February 2021
  • Shih MC, Elvis PR, Nguyen SA, Brennan E, Clemmens CS. Parental Presence at Induction of Anesthesia to Reduce Anxiety: A Systematic Research and Meta-Analysis. J Perianesth Nurs. 2023 Feb;38(1):12-20. doi: 10.1016/j.jopan.2022.03.008. Epub 2022 Jul 25. PubMed 35896422 ↗
  • Jerez C, Ullan AM, Lazaro JJ. Reliability and validity of the Spanish version of the modified Yale Preoperative Anxiety Scale. Rev Esp Anestesiol Reanim. 2016 Jun-Jul;63(6):320-6. doi: 10.1016/j.redar.2015.09.006. Epub 2015 Nov 26. English, Spanish. PubMed 26633606 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in Mar 2026, 28 months.

Of 3,859 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 28 months is above that.

Counting every sponsor, half of 3,962 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartActual
Nov 15, 2023
Primary completionActual
Mar 19, 2026
CompletionActual
Apr 15, 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943819
Lead sponsor
Hospital Mutua de Terrassa
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Nov 15, 2023
Primary completion
Mar 19, 2026
Completion
Apr 15, 2026
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion